Pfizer has signed an agreement with Switzerland-based Basilea Pharmaceutica for the exclusive development and commercialisation rights to Cresemba (isavuconazole) in...
Read moreCSL Limited and Vitaeris Inc.announced that they have entered into a strategic collaboration and purchase option agreement to expedite the...
Read moreThermo Fisher Scientific Inc., the world leader in serving science, today announced it has completed the acquisition of certain assets...
Read moreSQI Diagnostics Inc. announced it has successfully converted a multi-biomarker cardiac event prediction test from a pioneer in the field...
Read moreInnovest Global Inc. announced that it has signed a Letter of Intent to acquire a Commercial Energy business, which will...
Read moreEurofins Scientific, a global leader in bioanalytical testing, announces that it has acquired Spectro Analytical Labs Ltd. (“Spectro”), a leading...
Read moreAntares Pharma, Inc. announced that it has entered into a definitive asset purchase agreement to sell the worldwide rights, including...
Read moreMarken announced today the acquisition of Touchdown International Ltd, a privately held specialty logistics company in Taiwan, for an undisclosed...
Read moreCordenPharma, a leading Contract Development & Manufacturing Organization (CDMO), has entered into definite agreements to acquire the former Hospira Boulder...
Read moreCatalent, Inc. the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products,...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.